The first organoantimony(III) compounds possessing antitumor properties: diphenylantimony(III) derivatives of dithiophosphorus ligands

Anticancer Res. 1990 May-Jun;10(3):803-4.

Abstract

Two organoantimony (III) derivatives, i.e., diphenylantimony diphenyl-dithiophosphinate, Ph2SbS2PPh2, and diphenylantimony diizopropyldithiophosphate, Ph2SbS2P(OPri)2, were shown to exhibit antitumor properties. Both compounds produced strong tumor inhibition effects in mice bearing Ehrlich ascites tumor. Moreover, the dithiophosphate (15 mg/kg, i.p., in days 1, 3 and 5) produced a cure rate of 30%.

MeSH terms

  • Animals
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Ehrlich Tumor / drug therapy*
  • Drug Evaluation, Preclinical
  • Male
  • Mice
  • Organometallic Compounds / therapeutic use*
  • Organothiophosphorus Compounds / therapeutic use*

Substances

  • Antineoplastic Agents
  • Organometallic Compounds
  • Organothiophosphorus Compounds
  • diphenylantimony diphenyldithiophosphinate
  • diphenylantimony diisopropyldithiophosphate